Amy Edmonds serves as Executive at Bellerophon Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Amy Edmonds has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 22, 2019 involved selling 35,827 shares valued at $21.9K.
Amy Edmonds currently holds 140,216 shares of Bellerophon Therapeutics, Inc. (BLPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amy Edmonds has been a net neutral trader of BLPH stock. They have purchased $0 and sold $0 worth of shares.
Amy Edmonds's most recent insider trade was on May 22, 2019, when they sold 35,827 shares at $0.61 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 12, 2018 | BLPH | $17.8K | Payment | 7,499 | $2.37 | Discretionary |
| Jan 12, 2018 | BLPH | $0 | Award | 21,675 | $N/A | Discretionary |
| Mar 16, 2017 | BLPH | $0 | Award | 56,411 | $N/A | Discretionary |
| Sep 12, 2016 | BLPH | $18.4K | Payment | 13,301 | $1.38 | Discretionary |
| Jan 19, 2016 | BLPH | $0 | Award | 36,514 | $N/A | Discretionary |